Randomized, double-blind study to compare extended-release oxybutynin and tolterodine for overactive bladder

Obstetrics and Gynecology ◽

10.1016/s0029-7844(01)01263-7 ◽

2001 ◽

Vol 97 (5) ◽

pp. S49 ◽

Author(s):

P Sand

Keyword(s):

Overactive Bladder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Download Full-text

Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial

Mayo Clinic Proceedings ◽

10.4065/78.6.687 ◽

2003 ◽

Vol 78 (6) ◽

pp. 687-695 ◽

Author(s):

Ananias C. Diokno ◽

Rodney A. Appell ◽

Peter K. Sand ◽

Roger R. Dmochowski ◽

Bernard M. Gburek ◽

...

Keyword(s):

Overactive Bladder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Extended Release Formulations

Download Full-text

Randomized, Double-Blind Study to Compare Extended-Release Oxybutynin and Tolterodine for Overactive Bladder

Obstetrics and Gynecology ◽

10.1097/00006250-200104001-00121 ◽

2001 ◽

Vol 97 (Supplement) ◽

pp. 49S

Author(s):

Peter K. Sand ◽

Rodney Appell ◽

John R. Miklos ◽

Roger Dmochowski ◽

Detlef Albrecht

Keyword(s):

Overactive Bladder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Download Full-text

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83041-6 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1421-1432 ◽

Author(s):

John J Murray ◽

Eric Solomon ◽

Dennis McCluskey ◽

Jie Zhang ◽

Robert Palmer ◽

...

Keyword(s):

Extended Release ◽

Maxillary Sinusitis ◽

Immediate Release ◽

Adult Patients ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Download Full-text

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000304 ◽

2020 ◽

Vol 35 (3) ◽

pp. 137-146 ◽

Author(s):

Andrea Fagiolini ◽

Umberto Albert ◽

Laura Ferrando ◽

Erik Herman ◽

Cosmina Muntean ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Download Full-text

A randomized, double-blind study of OROS hydromorphone extended release (ER) compared to placebo in opioid-tolerant patients with moderate-to-severe osteoarthritis (OA) pain

Journal of Pain ◽

10.1016/j.jpain.2010.01.203 ◽

2010 ◽

Vol 11 (4) ◽

pp. S49

Author(s):

D. Taylor ◽

M. Kutch

Keyword(s):

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Download Full-text

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients With Major Depressive Disorder

American Journal of Geriatric Psychiatry ◽

10.1097/jgp.0b013e3182545e50 ◽

2012 ◽

pp. 1 ◽

Author(s):

Heikki Katila ◽

Irina Mezhebovsky ◽

Amy Mulroy ◽

Lovisa Berggren ◽

Hans Eriksson ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text

Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis

Clinical Therapeutics ◽

10.1016/s0149-2918(00)83040-4 ◽

2000 ◽

Vol 22 (12) ◽

pp. 1410-1420 ◽

Author(s):

Jay L Adler ◽

William Jannetti ◽

David Schneider ◽

Jie Zhang ◽

Robert Palmer ◽

...

Keyword(s):

Chronic Bronchitis ◽

Acute Exacerbation ◽

Extended Release ◽

Immediate Release ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Download Full-text

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s50248 ◽

2014 ◽

pp. 201 ◽

Author(s):

Gang Wang ◽

Alexander McIntyre ◽

Earley ◽

Shane Raines ◽

H Eriksson

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Major Depressive ◽

Double Blind ◽

Quetiapine Fumarate ◽

Download Full-text

A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design

Postgraduate Medicine ◽

10.1080/00325481.2018.1481712 ◽

2018 ◽

Vol 130 (5) ◽

pp. 481-493 ◽

Author(s):

Timothy Wigal ◽

Matthew Brams ◽

Glen Frick ◽

Brian Yan ◽

Manisha Madhoo

Keyword(s):

Extended Release ◽

Blind Study ◽

Double Blind Study ◽

Workplace Design ◽

Download Full-text

Urodynamic effects of intravesical nociceptin/orphanin FQ in patients with overactive bladder — A randomised, placebo-controlled, double-blind study

European Urology Supplements ◽

10.1016/s1569-9056(03)80283-x ◽

2003 ◽

Vol 2 (1) ◽

pp. 72 ◽

Author(s):

M. Lazzeri ◽

G. Calo ◽

M. Spinelli ◽

R. Guerrini ◽

S. Salvadori ◽

...

Keyword(s):

Overactive Bladder ◽

Blind Study ◽

Double Blind Study ◽

Orphanin Fq ◽

Download Full-text